Therapy Areas: Diabetes
Bayer's Kerendia wins FDA approval for chronic kidney disease associated with type 1 diabetes
17 September 2026 - German pharmaceutical and life sciences company Bayer AG (ETR:BAYN) (OTC:BAYRY) said on Thursday that the US Food and Drug Administration (FDA) has approved Kerendia (finerenone) t...
Meant Health announces expansion of telehealth access for FDA-approved GLP-1 prescriptions
14 September 2026 - Meant Health, a digital health platform that connects patients with licensed clinicians for evaluation, prescription and ongoing care coaching, announced on Saturday that it is exp...
Revvity to acquire Human Cell Design to expand metabolic disease drug discovery capabilities
9 September 2026 - Life sciences and diagnostics company Revvity Inc (NYSE:RVTY) announced on Wednesday that it has agreed to acquire France-based biotechnology company Human Cell Design (HCD), streng...
Foventa makes key CMO and CFO appointments
3 September 2026 - Foventa Therapeutics, a biotechnology company focused on novel therapies for retinal vascular diseases, announced on Wednesday that it has further strengthened its management team w...
Ascletis Pharma Inc doses first participant in global Phase III clinical programme of ASC30
31 August 2026 - Ascletis Pharma Inc. (Ascletis) (HKEX: 1672), a fully integrated biotechnology company, announced on Sunday that it has dosed its first participant in a global Phase III clinical prog...
Daiichi Sankyo data highlight real-world impact of bempedoic acid on cardiovascular risk
28 August 2026 - Japanese healthcare company Daiichi Sankyo Co Ltd (TYO:4568) said on Friday that new analyses from the multinational MILOS study demonstrate the real-world impact of bempedoic acid, u...